Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Burden of cardiometabolic risk factors and vascular health
American heart journal. 2024 Mar ; 269:201-204
Circ_ST6GAL1-mediated competing endogenous RNA network regulates TGF-β1-stimulated matrix Metalloproteinase-13 expression via Runx2 acetylation in osteoblasts
Non-coding RNA research. 2024 Mar ; 9:153-164
The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease
Cardiovascular research. 2024 Feb 17; 119:2813-2824
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities
Cardiovascular research. 2024 Feb 17; 119:2771-2773
Continuous glucose monitoring captures glycemic variability in obesity after sleeve gastrectomy: A prospective cohort study
Obesity science & practice. 2024 Feb 01; 10:?-?
Recipients of the 2024 Early Career Investigator Awards
Arteriosclerosis, thrombosis, & vascular biology. 2024 Feb 01;
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner
Metabolism clinical & experimental. 2024 Jan 09; 152:155784
Differential Effects of PTH (1-34), PTHrP (1-36), and Abaloparatide on the Murine Osteoblast Transcriptome
Journal of the Endocrine Society. 2024 Jan 01; 8:?-?